Blogs
Explore the latest insights & trends in clinical research: Our blog is your go-to source for innovative perspectives & expertise
Latest Blogs
Participant Experiences in a Hormonal Contraceptive Patch Study
Participating in a clinical trial can feel like a big decision, especially if it is your first time volunteering. In this blog, existing participants from a women’s hormonal patch study share their experience with BioPharma services, including how they felt trusted,...
How Acid-Reducing Drugs Like PPIs Interfere With Your Medications — And the FDA’s Stance
If you’ve ever taken a proton pump inhibitor (PPI) for heartburn or acid reflux, you’re in good company. These acid-reducing medications are widely used and available over the counter. But here’s something you might not know: they can alter how your body absorbs other...
The Critical Role of Targeted Data Capture; Enhancing Human Abuse Liability Studies
How Precision in Data Collection Shapes Outcomes and Informs Risk Assessment in Human Abuse Liability Research What is a HAL Study? A Human Abuse Liability (HAL) study is a critical tool in the pharmaceutical industry, designed to assess the abuse potential of drugs...
Pride in Research: Celebrating Inclusion and Diversity at BioPharma
Happy Pride Month, everyone! 🌈 At BioPharma Services, Pride Month is more than a rainbow logo or a single month of celebration. It’s a time to pause, reflect, and reaffirm something we deeply believe: every person who steps through our doors, whether as a trial...
Health Canada Confirms BioPharma Services Inc. in Full Compliance Following Successful QI Inspection
TORONTO, April 22, 2025 — BioPharma Services Inc., a leading global Contract Research Organization (CRO), is pleased to announce the successful completion of a comprehensive Quality Inspection (QI) by Health Canada at its clinical research facility. The inspection was...
Addressing Eight Misconceptions About Clinical Trials in Canada
Addressing Eight Misconceptions About Clinical Trials in CanadaHave you heard some common mistruths and misconceptions about medical trials in Canada? Each year, Health Canada authorizes close to 900 clinical trials. Unfortunately, misinformation is preventing some...
Role of the Institutional Review Boards (IRBs) at a Phase 1 CRO
Introduction to Institutional Review Boards (IRBs) An Institutional Review Board (IRB) is an independent committee that reviews, approves, and monitors biomedical research that involves human participants. The primary purpose of an Institutional Review Board is to...
Bioequivalence Studies: Designing an Effective Sampling Schedule
In pharmacokinetic analysis during the drug development processes, a well-structured sampling schedule is essential for accurately assessing the absorption, distribution, metabolism, and excretion (ADME) properties of a drug. However, missing data points remain...
Breaking Barriers: Exploring Rare Diseases and Orphan Drug Regulations in Canada
Rare diseases, often referred to as orphan diseases, affect a small percentage of the population. Despite their rarity, these conditions collectively impact millions of lives. In Canada, as in many other countries, the regulation and development of treatments for rare...
Clinical Chemists in Early Phase & Bioequivalence Studies
BioPharma Services Inc. is a Contract Research Organization (CRO) that plays a pivotal role in drug development by providing outsourced research services on a contractual basis. These clinical trials are designed to evaluate the safety and tolerability of new drugs,...
How Proof of Mechanism Studies Can Advance Clinical Drug Development
Drug development is a complex and lengthy process associated with high costs. Bringing a new medicine to the clinical practice has been estimated to cost on average over US$ 1 billion and to last more than 12 years. Moreover, there is a high attrition rate in drug...
Using Bayesian Statistical Methods in Clinical Trials Across Different Phases
Bayesian statistical methods are revolutionizing the design and analysis of clinical trials across all phases by allowing continuous adaptation and the incorporation of prior knowledge. Unlike the frequentist approach, which typically relies on fixed sample sizes and...
Optimizing DMF and MMF Clinical Trials: Managing Flushing with Aspirin
Dimethyl fumarate (DMF) is a medication used primarily to treat relapsing forms of multiple sclerosis (MS). Monomethyl fumarate (MMF) is a derivative of fumaric acid that contains a single methyl group attached to the fumarate backbone. They belong to a class of drugs...
Developing Formulations for Phase 1 Clinical Trials
Phase 1 clinical trials, including first-in-human studies, bridge preclinical and clinical drug development by being the first stage in drug development programs during which a New Chemical Entity (NCE) or Investigational Medicinal Product (IMP) is evaluated in...
Schedule a Discovery Call
Fill this form to request a call with our Sponsor Sales team.
You can unsubscribe at any time. For more details, please read our Privacy Policy.













